There have been no material changes with respect to the risk factors disclosed in our 2025 Annual Report on Form 10-K. Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities The following table provides information with respect to purchases of common stock made by the company during second quarter 2026: COMMON SHARE REPURCHASES DURING SECOND QUARTER 2026 TOTAL NUMBER OF SHARES PURCHASED AVERAGE PRICE PAID PER SHARE TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PROGRAMS APPROXIMATE DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PROGRAMS April 1 – April 30 — $ — — $ 928,405,205 May 1 – May 31 — $ — — $ 928,405,205 June 1 – June 30 409,734 $ 24.54 409,734 $ 918,350,650 Total 409,734 $ 24.54 409,734 32 During second quarter 2025, we completed the $1 billion purchase authorization under the share repurchase program approved by the board in September 2021 (the 2021 Repurchase Program). On May 8, 2025, we announced the board approved a new share repurchase program (the 2025 Repurchase Program) under which we are authorized to repurchase up to $1 billion of outstanding shares. Concurrently, the board of directors terminated the completed purchase authorization under the 2021 Repurchase Program. During second quarter 2026, we repurchased 409,734 shares for approximately $10 million (including transaction fees) under the 2025 Repurchase Program in open-market transactions. Transaction fees incurred for repurchases are not counted as use of funds authorized for repurchases under the 2025 Repurchase Program. As of June 30, 2026, we had remaining authorization of $918 million for future share repurchases.